BRIEF published on 11/05/2025 at 18:24, 5 months 25 days ago Leadership Transition at SCHOTT Pharma: Christian Mias Appointed CEO SCHOTT Pharma Leadership Transition Executive Appointment Pharmaceutical Growth Christian Mias
PRESS RELEASE published on 11/05/2025 at 18:19, 5 months 25 days ago SCHOTT Pharma: Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma Christian Mias appointed as CEO of SCHOTT Pharma, succeeding Andreas Reisse. Strategic leadership transition ensured for global pharmaceutical packaging leader Pharmaceutical SCHOTT Pharma CEO Christian Mias Andreas Reisse
BRIEF published on 11/05/2025 at 18:01, 5 months 25 days ago Christian Mias Appointed as New CEO of SCHOTT Pharma CEO Appointment SCHOTT Pharma Leadership Change Christian Mias Andreas Reisse
PRESS RELEASE published on 11/05/2025 at 17:56, 5 months 25 days ago EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: Christian Mias to succeed Andreas Reisse as CEO SCHOTT Pharma AG & Co. KGaA appoints Christian Mias as CEO to succeed Andreas Reisse, effective May 1, 2026. Inside information disclosed. Press release via EQS News Inside Information CEO Appointment SCHOTT Pharma EQS News Christian Mias
BRIEF published on 08/12/2025 at 07:05, 8 months 18 days ago SCHOTT Pharma Reports Steady Q3 2025 Results Innovation SCHOTT Pharma High-value Solutions Drug Containment Q3 2025 Results
PRESS RELEASE published on 08/12/2025 at 07:00, 8 months 18 days ago SCHOTT Pharma delivers solid final third-quarter results SCHOTT Pharma reports solid Q3 2025 results with 1% revenue growth, 32.4% EBITDA margin, and strategic innovations Revenue Growth EBITDA Margin SCHOTT Pharma Innovations Q3 2025 Results
BRIEF published on 08/05/2025 at 10:00, 8 months 25 days ago SCHOTT Pharma's Q3 2025 Highlights and FY 2025 Outlook Revenue Growth EBITDA Margin Financial Outlook Q3 2025 High Value Solutions
BRIEF published on 08/05/2025 at 09:58, 8 months 25 days ago SCHOTT Pharma Updates FY 2025 Revenue and EBITDA Guidance Financial Results Revenue Growth EBITDA Margin SCHOTT Pharma FY 2025 Guidance
PRESS RELEASE published on 08/05/2025 at 09:55, 8 months 25 days ago SCHOTT Pharma reports preliminary results for Q3 2025 and specifies FY 2025 guidance SCHOTT Pharma reports Q3 2025 revenues up 3% yoy at EUR 256m and gives FY 2025 guidance with EBITDA expected to be around 28.0%. Full financial results to be published on August 12, 2025 Revenues EBITDA SCHOTT Pharma Q3 2025 FY 2025 Guidance
PRESS RELEASE published on 08/05/2025 at 09:53, 8 months 25 days ago EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma specifies FY 2025 guidance for revenue growth and EBITDA margin SCHOTT Pharma AG & Co. KGaA specifies FY 2025 guidance for revenue growth and EBITDA margin, expecting 6.0% organic revenue growth and 28.0% EBITDA margin Revenue Growth EBITDA Margin SCHOTT Pharma Guidance FY 2025
Published on 04/30/2026 at 21:00, 1 hour 10 minutes ago Datavault AI Schedules Conference Call to Discuss First Quarter 2026 Financial Results on Friday, May 15, 2026
Published on 04/30/2026 at 19:00, 3 hours 10 minutes ago Caldwell Announces Appointment of Shawn Banerji as Co-Leader of Technology Practice
Published on 04/30/2026 at 16:00, 6 hours 10 minutes ago CORRECTION FROM SOURCE: Rio Grande Resources Announces Results from its Airborne Survey at Winston Gold/Silver Project, New Mexico and Announces New President
Published on 04/30/2026 at 15:35, 6 hours 35 minutes ago Nepra Foods Enters Letter of Intent to Acquire Idaho Bottling and Water Assets, Advancing Vertical Integration Strategy
Published on 04/30/2026 at 15:10, 7 hours ago Formation Metals Announces Non-Brokered Offering of up to $15 Million Fully Allocated
Published on 04/30/2026 at 22:04, 6 minutes ago Interim individual financial statements for the period ending on March 31, 2026 of Sirma Group Holding JSC
Published on 04/30/2026 at 19:00, 3 hours 9 minutes ago DOUGLAS Group grows sales in Q2 and updates full-year guidance on adjusted EBITDA
Published on 04/30/2026 at 19:00, 3 hours 10 minutes ago BioVersys announces approval of all Board Proposals at Annual General Meeting of Shareholders
Published on 04/30/2026 at 18:59, 3 hours 11 minutes ago Sirma Group Holding published its Invitation for Annual Regular General Shareholder Meeting
Published on 04/30/2026 at 18:41, 3 hours 28 minutes ago Ørsted completes divestment of its European onshore business
Published on 04/30/2026 at 20:00, 2 hours 9 minutes ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 2 hours 54 minutes ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 3 hours 10 minutes ago Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 4 hours ago Minutes of the Combined General Meeting held on April 30, 2026
